date:May 24, 2019
g the trace-back activities in response to random sample testing by FSIS.
So far, there have been no confirmed reports of adverse reactions as a result of the consumption of the products. FSIS said that anyone concerned about a reaction should contact a healthcare provider.
Customers have been urged not to consume the products and to either throw them away or return them to the sellers.
This has been classified as a Class I recall, indicating a health hazard situation where there is a reasona